A Switch Study of BMS-337039 in Schizophrenic Out-patients

NCT00232687 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Aripiprazole
DRUG: Aripiprazole

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]